Professional Summary
Professional Overview
Amy Elazzouzi is a seasoned finance executive with over 20 years of experience in the biopharmaceutical industry. As the Vice President of Finance at Aura Biosciences, she is responsible for leading the company's financial strategy, reporting, and operational excellence initiatives.
Experience Summary
Current Role
As the Vice President of Finance at Aura Biosciences, a clinical-stage biotechnology company focused on developing novel therapies for eye diseases, Amy is responsible for overseeing all financial and accounting functions. In this role, she has streamlined financial processes, improved reporting, and played a key role in securing additional funding to support the company's pipeline development. Under her leadership, Aura Biosciences has achieved significant milestones, including the successful completion of a $100 million Series D financing round.
Career Progression
Prior to her current role, Amy held several finance leadership positions at various biopharmaceutical companies. She served as the Corporate Controller at Aura Biosciences, where she was instrumental in implementing robust financial controls and systems. Before that, she was the Director of Finance and Operations at KEW Group Inc., where she led the company's financial and operational strategy. Earlier in her career, Amy held roles as a Controller and Business Manager at AVEO Oncology, where she played a crucial role in managing the company's financial operations and supporting its growth.
Academic Background
Amy holds a Bachelor of Science in Accounting from the University of Massachusetts Amherst. She is a Certified Public Accountant (CPA) and has participated in various executive development programs, further enhancing her leadership and strategic finance skills.
Areas of Expertise
- Financial planning and analysis
- Accounting and reporting
- Budgeting and forecasting
- Regulatory compliance
- Fundraising and investor relations
- Process optimization and operational efficiency
- Cross-functional collaboration and team leadership
Professional Impact
Throughout her career, Amy has demonstrated a strong commitment to driving financial excellence and operational efficiency within the biopharmaceutical industry. Her strategic insights, financial acumen, and ability to navigate complex regulatory environments have been instrumental in supporting the growth and success of the companies she has worked with. Amy is known for her collaborative approach, data-driven decision-making, and her ability to develop and mentor high-performing finance teams.
Conclusion
With her extensive experience, deep industry knowledge, and proven track record of financial leadership, Amy Elazzouzi is a valuable asset to Aura Biosciences. She is passionate about leveraging her expertise to support the company's mission of developing innovative therapies and creating long-term value for its stakeholders.
